Altered peptide ligands and MS treatment

Science. 2002 Jun 7;296(5574):1801-2; author reply 1801-2. doi: 10.1126/science.296.5574.1801c.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Controlled Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Ligands
  • Multicenter Studies as Topic
  • Multiple Sclerosis / drug therapy*
  • Peptide Fragments / adverse effects*
  • Peptide Fragments / therapeutic use*

Substances

  • Ligands
  • Peptide Fragments